Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Reicher Murray A.	2. Issuer Name and Ticker or Trading Symbol MERGE HEALTHCARE INC [ MRGE ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chief Medical Officer
(Last) (First) (Middle) 350 NORTH ORLEANS STREET, FIRST FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 2/26/2015
(Street) CHICAGO, IL 60654 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	2/26/2015		P		900	A	$3.76	900	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		200	A	$3.765	1100	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		6100	A	$3.77	7200	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		83	A	$3.775	7283	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		717	A	$3.78	8000	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		2000	A	$3.79	10000	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		200	A	$3.80	10200	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		100	A	$3.805	10300	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		500	A	$3.81	10800	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		1300	A	$3.82	12100	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		1200	A	$3.83	13300	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		4500	A	$3.84	17800	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		400	A	$3.85	18200	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		500	A	$3.86	18700	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		2075	A	$3.87	20775	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		200	A	$3.875	20975	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		4800	A	$3.8779	25775	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		4225	A	$3.88	30000	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		700	A	$3.89	30770	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		15300	A	$3.90	46000	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		100	A	$3.905	46100	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		800	A	$3.91	46900	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		1300	A	$3.9143	48200	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		200	A	$3.915	48400	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		3300	A	$3.9151	51700	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		4700	A	$3.917	56400	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		100	A	$3.9175	56500	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		4700	A	$3.9199	61200	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		5101	A	$3.92	66301	I	Trust ⁽¹⁾
Common Stock	2/26/2015		P		100	A	$3.9275	66401	I	Trust ⁽¹⁾

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:
( 1)	Shares of Common Stock held by the Reicher Family Trust, of which Murray A. Reicher and Danielle M. Reicher are the Trustees, the beneficial ownership of which Dr. Reicher disclaims.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Reicher Murray A. 350 NORTH ORLEANS STREET FIRST FLOOR CHICAGO, IL 60654			Chief Medical Officer

Signatures
Julie Ann B. Schumitsch, by Power of Attorney for Murray A. Reicher		3/2/2015
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.